Bruker AXS announces the promotions of Frank Burgazy, Roger Durst, and Bernard Kolodziej to executive vice presidents
The newly appointed Bruker AXS executive management team will be responsible for leading all aspects of the Bruker AXS business, including global sales and marketing, customer support, manufacturing, research and development, operations and financial management.
Frank Burgazy now leads the Bruker AXS X-ray diffraction (XRD) business as well as its X-ray fluorescence (XRF) business, and also has global responsibility for marketing at Bruker AXS.
Burgazy is based in Karlsruhe, Germany, and has been the global XRD business manager since September 2002.
From 1990 to 2002, Burgazy held several scientific, product management and other management positions at Siemens AXS and later Bruker AXS.
He studied physics at the University of Stuttgart and at Oregon State University, and he earned his doctorate in physics at the Max-Planck Institute in Stuttgart, Germany.
Roger Durst now leads the Bruker AXS X-ray single crystal diffraction (SCD) business, and as chief technology officer heads global R and D.
Durst is based in Madison, Wisconsin, and previously has managed the same functions as vice president.
Durst joined Siemens AXS in 1996 as a development scientist and has held several scientific and management positions at Bruker AXS.
He received his SB in aeronautics and astronautics from the Massachusetts Institute of Technology and his PhD in physics from the University of Texas at Austin.
Bernard Kolodziej now leads the global finance function and European operations, as well as many of the worldwide subsidiaries of Bruker AXS.
Kolodziej is based in Karlsruhe, Germany, and has been vice president of finance since April 2004.
Previously, Kolodziej was CFO of European operations since January 1999.
Between 1995 and 1999, he held several operations and financial positions within Siemens AXS and later Bruker AXS.
Kolodziej has a master's degree in business administration, finance and production engineering from the University of Karlsruhe, Germany.
Frank Laukien, president and CEO of Bruker BioSciences, said: "We are fortunate to have this team of seasoned and successful executives provide continued and expanded leadership to Bruker AXS.
"Each of the new executive vice presidents has an outstanding record of accomplishment.
"I am confident that, together with our established senior management team, they will continue to drive Bruker AXS's growth and financial performance through innovation, successful product development and responsive customer support, as well as operational excellence and margin improvements".
